CIPLANSECipla Limited· PharmaceuticalsMediumNeutral
Announced Tue, 13 May · 14:00 IST

Cipla Limited has informed the Exchange regarding Appointment of M/s B S R & Co. LLP as Statutory Auditor of the company

Management Changes View source PDF

CIPLA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Cipla's Board, on the recommendation of the Audit Committee, approved three auditor-related decisions on 13th May 2025. M/s Joshi Apte & Associates has been appointed as Cost Auditor for FY 2025-26. M/s BNP & Associates has been recommended as Secretarial Auditor for a five-year term from April 2025 to March 2030, subject to shareholder approval. Most importantly, M/s B S R & Co. LLP has been recommended as the new Statutory Auditor for a five-year term, replacing Walker Chandiok & Co LLP, which completes its second (and final) five-year term at the conclusion of the 90th AGM. B S R & Co. LLP is a large, well-established audit firm with over 140 partners and 4,000+ staff, part of the B S R & Affiliates network registered with ICAI. Shareholder approval for the statutory and secretarial auditor appointments will be sought at upcoming AGMs.

Likely market impact

This is a routine, regulation-driven transition. The change in statutory auditor is due to Walker Chandiok completing its maximum allowed tenure under SEBI rules, not due to any governance concerns. The appointment of B S R & Co. LLP, a reputable large audit firm, is unlikely to have any material impact on the stock price and should not affect financial reporting continuity.